Skip to main content
main-content

Zeitschrift

Cancer Immunology, Immunotherapy

Cancer Immunology, Immunotherapy 4/2020

Ausgabe 4/2020

Inhaltsverzeichnis ( 15 Artikel )

16.01.2020 | Original Article | Ausgabe 4/2020 Open Access

CD16 pre-ligation by defucosylated tumor-targeting mAb sensitizes human NK cells to γc cytokine stimulation via PI3K/mTOR axis

Cristina Capuano, Chiara Pighi, Roberta Maggio, Simone Battella, Stefania Morrone, Gabriella Palmieri, Angela Santoni, Christian Klein, Ricciarda Galandrini

01.04.2020 | Original Article | Ausgabe 4/2020 Open Access

High expression of ID1 in monocytes is strongly associated with phenotypic and functional MDSC markers in advanced melanoma

Jeroen Melief, Yago Pico de Coaña, Roeltje Maas, Felix-Lennart Fennemann, Maria Wolodarski, Johan Hansson, Rolf Kiessling

01.04.2020 | Original Article | Ausgabe 4/2020 Open Access

Immune profile and immunosurveillance in treatment-naive and neoadjuvantly treated esophageal adenocarcinoma

Svenja Wagener-Ryczek, Max Schoemmel, Max Kraemer, Christiane Bruns, Wolfgang Schroeder, Thomas Zander, Florian Gebauer, Hakan Alakus, Sabine Merkelbach-Bruse, Reinhard Buettner, Heike Loeser, Martin Thelen, Hans A. Schlößer, Alexander Quaas

21.01.2020 | Original Article | Ausgabe 4/2020

Enhanced glucose metabolism mediated by CD147 contributes to immunosuppression in hepatocellular carcinoma

Xiaofeng Li, Yufan Zhang, Wenchao Ma, Qiang Fu, Jianjing Liu, Guotao Yin, Peihe Chen, Dong Dai, Wei Chen, Lisha Qi, Xiaozhou Yu, Wengui Xu

22.01.2020 | Original Article | Ausgabe 4/2020

The expression and prognostic impact of proinflammatory cytokines and their associations with carcinogens in oropharyngeal squamous cell carcinoma

Chi-Maw Lin, Long-Wei Lin, Ya-Wen Chen, Yi-Ling Ye

23.01.2020 | Original Article | Ausgabe 4/2020 Open Access

The neutrophil–lymphocyte ratio and locoregional melanoma: a multicentre cohort study

Alyss V. Robinson, Claire Keeble, Michelle C. I. Lo, Owen Thornton, Howard Peach, Marc D. S. Moncrieff, Donald J. Dewar, Ryckie G. Wade

24.01.2020 | Original Article | Ausgabe 4/2020

Treatment with an immature dendritic cell-targeting vaccine supplemented with IFN-α and an inhibitor of DNA methylation markedly enhances survival in a murine melanoma model

James T. Gordy, Kun Luo, Aakanksha Kapoor, Emily S. Kim, Samuel K. Ayeh, Petros C. Karakousis, Richard B. Markham

24.01.2020 | Original Article | Ausgabe 4/2020 Open Access

Digital pathology-aided assessment of tumor-infiltrating T lymphocytes in advanced stage, HPV-negative head and neck tumors

Emma J. de Ruiter, Reinout H. de Roest, Ruud H. Brakenhoff, C. René Leemans, Remco de Bree, Chris H. J. Terhaard, Stefan M. Willems

25.01.2020 | Original Article | Ausgabe 4/2020 Open Access

Suppressive activity of Vδ2+ γδ T cells on αβ T cells is licensed by TCR signaling and correlates with signal strength

Karin Schilbach, Naomi Krickeberg, Carlotta Kaißer, Simon Mingram, Janika Kind, Gabrielle M. Siegers, Hisayoshi Hashimoto

30.01.2020 | Original Article | Ausgabe 4/2020

PKCζ mediated anti-proliferative effect of C2 ceramide on neutralization of the tumor microenvironment and melanoma regression

Sweta Ghosh, Subir Kumar Juin, Partha Nandi, Suchandra Bhattacharyya Majumdar, Anamika Bose, Rathindranath Baral, Parames C. Sil, Subrata Majumdar

04.02.2020 | Original Article | Ausgabe 4/2020

Specific T-cell immune responses against colony-forming cells including leukemic progenitor cells of AML patients were increased by immune checkpoint inhibition

Jochen Greiner, Marlies Götz, Susanne Hofmann, Hubert Schrezenmeier, Markus Wiesneth, Lars Bullinger, Hartmut Döhner, Vanessa Schneider

04.02.2020 | Original Article | Ausgabe 4/2020

Bovine papillomavirus prostate cancer antigen virus-like particle vaccines are efficacious in advanced cancers in the TRAMP mouse spontaneous prostate cancer model

Brian W. Simons, Fabiana Cannella, Dayana T. Rowley, Raphael P. Viscidi

05.02.2020 | Original Article | Ausgabe 4/2020

Response to ipilimumab therapy in metastatic melanoma patients: potential relevance of CTLA-4+ tumor infiltrating lymphocytes and their in situ localization

Luca Mastracci, Vincenzo Fontana, Paola Queirolo, Roberta Carosio, Federica Grillo, Anna Morabito, Barbara Banelli, Enrica Tanda, Andrea Boutros, Beatrice Dozin, Marina Gualco, Sandra Salvi, Massimo Romani, Francesco Spagnolo, Alessandro Poggi, Maria Pia Pistillo

24.01.2020 | Clinical Trial Report | Ausgabe 4/2020 Open Access

First-in-human phase I clinical trial of the NY-ESO-1 protein cancer vaccine with NOD2 and TLR9 stimulants in patients with NY-ESO-1-expressing refractory solid tumors

Mikiya Ishihara, Yasutaka Tono, Yoshihiro Miyahara, Daisuke Muraoka, Naozumi Harada, Shinichi Kageyama, Takeshi Sasaki, Yasuhide Hori, Norihito Soga, Katsunori Uchida, Taizo Shiraishi, Eiichi Sato, Hideki Kanda, Toshiro Mizuno, Gill A. Webster, Hiroaki Ikeda, Naoyuki Katayama, Yoshiki Sugimura, Hiroshi Shiku

02.03.2020 | Meeting Report | Ausgabe 4/2020 Open Access

International Regensburg Center for Interventional Immunology (RCI) symposium on “Synthetic immunology and environment-adapted redirection of T cells”, 17–18 July, 2019, Regensburg, Germany

Philipp Beckhove, Matthias Edinger, Markus Feuerer, Luca Gattinoni, Hinrich Abken

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise